Aster Capital Management (Difc) LTD Veracyte, Inc. Transaction History
Aster Capital Management (Difc) LTD
- $262 Billion
- Q4 2024
A detailed history of Aster Capital Management (Difc) LTD transactions in Veracyte, Inc. stock. As of the latest transaction made, Aster Capital Management (Difc) LTD holds 45 shares of VCYT stock, worth $1,817. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45Holding current value
$1,817% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VCYT
# of Institutions
328Shares Held
81.9MCall Options Held
134KPut Options Held
13.3K-
Vanguard Group Inc Valley Forge, PA8.21MShares$332 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$315 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI6.6MShares$266 Million0.42% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.2MShares$170 Million1.46% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$165 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.89B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...